[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100596843":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":25,"centralContacts":33,"locations":43,"responsibleParty":61,"collaborators":63,"id":76,"slug":77,"hasResults":78,"nctId":79,"briefTitle":80,"officialTitle":80,"acronym":81,"eligibilityCriteria":82,"healthyVolunteers":83,"sex":84,"minAge":85,"maxAge":86,"enrollmentInfo":87,"targetDuration":18,"studyType":90,"phases":91,"briefSummary":93,"conditions":94,"keywords":98,"overallStatus":45,"whyStopped":18,"lastUpdateSubmitDate":106,"lastUpdatePostDateStruct":107,"startDateStruct":110,"completionDateStruct":112,"leadSponsor":114,"locationsCount":115},{"fullName":5,"class":6},"Kenyatta National Hospital","OTHER_GOV",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"DADA-LINK Integrated Care Package: HPV Self-Sampling, Care Navigation, and mHealth support","EXPERIMENTAL","Intervention facilities will receive the DADA-LINK multi-component integrated care package comprised of HPV self-sampling, care navigation, and mHealth support.",[13],"Behavioral: DADA LINK",{"label":15,"type":16,"description":17,"interventionNames":18},"Routine standard of care for cervical cancer screening, linkage and treatment","NO_INTERVENTION","Clinics randomized to the control arm will continue with usual care practices for cervical cancer screening, triage, and treatment",null,[20],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":18},"BEHAVIORAL","DADA LINK","Intervention facilities will receive the DADA-LINK intervention, comprised of:\n\n1. HPV self-sampling: We will provide clinics with HPV self-sampling kits to administer to eligible patients.\n2. Care Navigation: One study-supported non-physician care navigator will be assigned to each clinic to support the clinic staff. These trained individuals will be responsible for managing data collection through the mHealth platform to aid the coordination of services and for motivating the clinic staff to adhere to cervical cancer care guidelines.\n3. mHealth support for cervical cancer screening and treatment linkage: The WEMA application is a low-cost and highly adaptable open-source application designed for cervical cancer data monitoring and evaluation. Relevant patient information and data on uptake of cervical cancer screening and triage\u002Ftreatment will be entered in the WEMA platform. The platform will additionally be used to send text messages to patients to facilitate clinic attendance.",[9],[26,30],{"name":27,"affiliation":28,"role":29},"Rose J Kosgei, MBChB,MMed,MSc,Fell.GynOnc,PhD","University of Nairobi","PRINCIPAL_INVESTIGATOR",{"name":31,"affiliation":32,"role":29},"Leslie Johnson, MPH, MLitt, PhD","Emory University",[34,39],{"name":35,"role":36,"phone":37,"phoneExt":18,"email":38},"Agnes K Karume, MBChB, MBA, MPH","CONTACT","+254715181283","karumeagnes@gmail.com",{"name":40,"role":36,"phone":41,"phoneExt":18,"email":42},"Millicent Masinde, MBChB, MMed, Fell.Gyn Oncology","+254721243740","dr.msmillies@gmail.com",[44],{"facility":5,"status":45,"city":46,"state":18,"zip":18,"country":47,"countryCode":48,"cosmosGeoPoint":49,"geoPoint":54,"contacts":55},"RECRUITING","Nairobi","Kenya","KE",{"type":50,"coordinates":51},"Point",[52,53],36.81667,-1.28333,{"lat":53,"lon":52},[56,57,59],{"name":35,"role":36,"phone":37,"phoneExt":18,"email":38},{"name":40,"role":36,"phone":41,"phoneExt":18,"email":58},"masinde@uw.edu",{"name":60,"role":29,"phone":18,"phoneExt":18,"email":18},"Rose Kosgei, MBChB,MMed,MSc,Fell.GynOnc,PhD",{"type":62,"investigatorFullName":18,"investigatorTitle":18,"investigatorAffiliation":18,"oldNameTitle":18,"oldOrganization":18},"SPONSOR",[64,66,68,71,73,75],{"name":32,"class":65},"OTHER",{"name":67,"class":65},"University of Washington",{"name":69,"class":70},"National Cancer Institute (NCI)","NIH",{"name":72,"class":6},"Kenya Ministry of Health",{"name":74,"class":65},"Queen's University",{"name":28,"class":65},"100596843","accelerating-adoption-of-patient-centered-cervical-cancer-screening-and-treatment-linkage-in-kenya-100596843",false,"NCT07050745","Accelerating Adoption of Patient-centered Cervical Cancer Screening and Treatment Linkage in Kenya","DADA-LINK","Inclusion Criteria:\n\n\\- Women ages 25-49 years\n\nExclusion Criteria:\n\n* Pregnant women\n* Women ≤6 weeks postpartum\n* Women already confirmed to have cervical cancer",true,"FEMALE","25 Years","49 Years",{"count":88,"type":89},1980,"ESTIMATED","INTERVENTIONAL",[92],"NA","This study aims to test the use of a multi-component care strategy (DADA LINK) designed to improve cervical cancer screening and linkage to treatment. The duration of the trial is 12 months, with a 6-month follow-up period to evaluate intervention costs and measure maintenance of the care strategies. Study staff at each clinic will abstract data on cervical cancer screening and triage\u002Ftreatment. Clinics randomized to the intervention arm will have care coordinators who motivate clinic staff to adhere to cervical cancer care guidelines, conduct patient exit surveys to assess intervention fidelity, and support care coordination through use of the mHealth platform (WEMA).",[95,96,97],"Cervical Cancer","Cervical Cancer Screening","HPV DNA",[99,100,101,102,103,104,105],"cervical cancer","screening","m-Health","linkage to treatment","VIA","HPV","HPV self-sampling","2026-01-08",{"date":108,"type":109},"2026-01-12","ACTUAL",{"date":111,"type":109},"2025-12-01",{"date":113,"type":89},"2026-12",{"name":5,"class":6},1]